Live Quote · NASDAQSPRYHealthcare· Biotechnology

ARS Pharmaceuticals, Inc.

$2.96▼ 11.90%($-0.40)
MKT CAP $297.56MNEXT EARNINGS Mar 8, 2027
50%
Bullish
TickerSpark Score
45/100
▌ Weak
67
Valuation
60
Profitability
10
Growth
60
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPRY research report →

Analyst Price Target
$15.00+406.8% vs. today

Range $15 – $15

Analyst RatingHold
4 Buy6 Hold0 Sell

Price Chart

-56.02% · this period
$13.06$7.86$2.65Nov 20May 26Nov 20
52-Week Range5% of range
Low
$2.44
Current
$2.96
High
$13.15